HistoSonics Stock
HealthTechLooking to sell HistoSonics stock or options?
HistoSonics has developed a non-invasive, robotically assisted ultrasound therapy device designed for precise tissue destruction. This innovative device uses focused sound energy to mechanically break down targeted tissue at a sub-cellular level, providing continuous visualization, real-time physician control, and personalized treatment adjustments. It operates without incisions or needles, integrating advanced imaging and adaptive energy delivery. This enables healthcare providers to treat unresectable tumors with improved accuracy, reduced procedural complexity, and minimized patient recovery time.
Grand Rapids Business Journal, Gary Comer, HealthQuest Capital, Alpha Wave Global, Varian Medical Systems, Johnson & Johnson Innovation - JJDC, Frederic Moll, Amzak Health, Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Trout Creek Ventures, State of Wisconsin Investment Board, Early Stage Partners, Lumira Ventures, Grand Angels, Yonjin Venture, Innovation Partnerships, TGap Ventures, Samuel Zell & Robert H Lurie, MINTS (Michigan Investment in New Technology Startups), Michigan Capital Network, Daniel Weide, Northern Michigan Angels.